United States: Fox Corporate Team Leads Major MedTech Acquisition
Last Updated: April 28 2016

A team of Fox Rothschild LLP corporate attorneys, led by D. William Kaufman and Kiel C. McElveen, represented NeuWave Medical, Inc., of Madison, Wis., through a major acquisition by Ethicon Endo-Surgery, Inc., a medical device company, which is part of the Johnson & Johnson family of companies.

NeuWave is a privately held medical device company that manufactures and markets minimally invasive soft-tissue microwave ablation systems. Its products, currently used by physicians in more than half of the top cancer centers in the United States, and its mission aligned well with Johnson & Johnson Medical Devices' strategy of advancing innovation and investing in areas of unmet medical needs such as surgical oncology.

"This acquisition now provides NeuWave Medical with the ability to accelerate our innovation pipeline and expand the global footprint of our unique technologies, while allowing Ethicon to reach new patients by expanding the availability of a novel intervention that goes beyond surgical options in wide use today," said Dan Sullivan, the CEO and President of NeuWave Medical in connection with the April 14, 2016, release announcing the transaction.

"Dan Sullivan and I have worked together for nearly three decades and through four M&A deals," said Kaufman. "I was thrilled to have been able to guide NeuWave through this transaction that will benefit people around the world by making this cutting edge medical technology available to the masses."

Financial terms of the transaction, which closed on April 13, 2016, have not been disclosed.

Kaufman and McElveen were assisted on this deal by Fox Rothschild attorneys Gina B. DeConcini, Phillip B. Martin, Pamela A. Thein, Sandi De Boom and Cynthia S. Topel.

For nearly 40 years, Kaufman, a partner with Fox, has worked closely with emerging businesses and venture capital funds to help them realize their business objectives. During the course of his career, he has successfully closed more than 280 venture capital transactions and handled numerous sales of venture-backed companies to large strategic investors. He regularly advises clients on organization selection, equity financing structures, debt financing, technology licenses, domestic and international distribution arrangements, strategic investments, spin-off transactions, clinical trial agreements and M&A transactions.

McElveen, an associate with the firm, advises both emerging and established companies in a wide variety of mergers and acquisitions, private financings, capital markets transactions and securities compliance matters. He has assisted with mergers and acquisitions involving both private and public companies and represents clients in a broad range of matters, including corporate governance and restructuring.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Press Releases from this Firm
Recent Content from this Firm
By Alka Bahal
By GlobeSt .com
By National Real Estate Investor
By Melissa Lyon
By Jessica Diamond
By Mark Tabakman
By William Levinson
By Melissa Lyon
By Alexander Radus
By James Singer
Tools
Print
Font Size:
Translation
Channels